Loading…
Factors Associated with Uptake of Routine Measles-Containing Vaccine Doses among Young Children, Oromia Regional State, Ethiopia, 2021
Recommended vaccination at nine months of age with the measles-containing vaccine (MCV1) has been part of Ethiopia's routine immunization program since 1980. A second dose of MCV (MCV2) was introduced in 2019 for children 15 months of age. We examined MCV1 and MCV2 coverage and the factors asso...
Saved in:
Published in: | Vaccines (Basel) 2024-07, Vol.12 (7), p.762 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c385t-677d272e2eeaa7ec5650483e7b001197d1ea3588e5190de94dc5495aa4fcab433 |
container_end_page | |
container_issue | 7 |
container_start_page | 762 |
container_title | Vaccines (Basel) |
container_volume | 12 |
creator | Woyessa, Abyot Bekele Shah, Monica P Azmeraye, Binyam Moges Pan, Jeff Lisanwork, Leuel Yimer, Getnet Wang, Shu-Hua Nuorti, J Pekka Artama, Miia Matanock, Almea M An, Qian Samuel, Paulos Tolera, Bekana Kenate, Birhanu Bekele, Abebe Deti, Tesfaye Wako, Getachew Shiferaw, Amsalu Tefera, Yohannes Lakew Kokebie, Melkamu Ayalew Anbessie, Tatek Bogale Wubie, Habtamu Teklie Wallace, Aaron Sugerman, Ciara E |
description | Recommended vaccination at nine months of age with the measles-containing vaccine (MCV1) has been part of Ethiopia's routine immunization program since 1980. A second dose of MCV (MCV2) was introduced in 2019 for children 15 months of age. We examined MCV1 and MCV2 coverage and the factors associated with measles vaccination status. A cross-sectional household survey was conducted among caregivers of children aged 12-35 months in selected districts of Oromia Region. Measles vaccination status was determined using home-based records, when available, or caregivers' recall. We analyzed the association between MCV1 and MCV2 vaccination status and household, caregiver, and child factors using logistic regression. The caregivers of 1172 children aged 12-35 months were interviewed and included in the analysis. MCV1 and MCV2 coverage was 71% and 48%, respectively. The dropout rate (DOR) from the first dose of Pentavalent vaccine to MCV1 was 22% and from MCV1 to MCV2 was 46%. Caregivers were more likely to vaccinate their children with MCV if they gave birth at a health facility, believe that their child had received all recommended vaccines, and know the required number of vaccination visits and doses. MCV2 coverage was low, with a high measles dropout rate (DOR). Caregivers with high awareness of MCV and its schedule were more likely to vaccinate their children. Intensified demand generation, defaulter tracking, and vaccine-stock management should be strengthened to improve MCV uptake. |
doi_str_mv | 10.3390/vaccines12070762 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_9b5b3d6aeb9a4137aaa7614e5887fcdf</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A803776607</galeid><doaj_id>oai_doaj_org_article_9b5b3d6aeb9a4137aaa7614e5887fcdf</doaj_id><sourcerecordid>A803776607</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-677d272e2eeaa7ec5650483e7b001197d1ea3588e5190de94dc5495aa4fcab433</originalsourceid><addsrcrecordid>eNptUs1u1DAQjhCIVqV3TsgSFw67xY5jOzmulhYqFVUqFMHJmtiTXS9JvNgOiBfguXFJKVBhS57R6PsZ21MUTxk94byhL7-CMW7EyEqqqJLlg-IwZ3LJG_7x4V_5QXEc447m1TBeS_W4OMh0KStKD4sfZ2CSD5GsYvTGQUJLvrm0Jdf7BJ-R-I5c-SllH_IWIfYYl2s_JnCjGzfkw9wCeeUjRgKDz7VPfsrneut6G3BckMvgBwfkCjfOj9CTdymbLMhp2jq_d7AgJS3Zk-JRB33E49t4VFyfnb5fv1leXL4-X68ulobXIi2lUrZUJZaIAAqNkIJWNUfVUspYoyxD4KKuUbCGWmwqa0TVCICqM9BWnB8V57Ou9bDT--AGCN-1B6d_FXzYaAjJmR5104qWWwnYNlAxriA7SlZhlledsV3WejFr7YP_MmFMenDRYN_DiH6KmtNa5L-p6zJDn9-D7vwU8mvMKCpkWYo_qA1kfzd2PgUwN6J6VVOulJRUZdTJf1B5Wxyc8SN2Ltf_IdCZYIKPMWB3d29G9c0k6fuTlCnPbvud2gHtHeH33PCfBBvDeQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3085056225</pqid></control><display><type>article</type><title>Factors Associated with Uptake of Routine Measles-Containing Vaccine Doses among Young Children, Oromia Regional State, Ethiopia, 2021</title><source>Access via ProQuest (Open Access)</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Woyessa, Abyot Bekele ; Shah, Monica P ; Azmeraye, Binyam Moges ; Pan, Jeff ; Lisanwork, Leuel ; Yimer, Getnet ; Wang, Shu-Hua ; Nuorti, J Pekka ; Artama, Miia ; Matanock, Almea M ; An, Qian ; Samuel, Paulos ; Tolera, Bekana ; Kenate, Birhanu ; Bekele, Abebe ; Deti, Tesfaye ; Wako, Getachew ; Shiferaw, Amsalu ; Tefera, Yohannes Lakew ; Kokebie, Melkamu Ayalew ; Anbessie, Tatek Bogale ; Wubie, Habtamu Teklie ; Wallace, Aaron ; Sugerman, Ciara E</creator><creatorcontrib>Woyessa, Abyot Bekele ; Shah, Monica P ; Azmeraye, Binyam Moges ; Pan, Jeff ; Lisanwork, Leuel ; Yimer, Getnet ; Wang, Shu-Hua ; Nuorti, J Pekka ; Artama, Miia ; Matanock, Almea M ; An, Qian ; Samuel, Paulos ; Tolera, Bekana ; Kenate, Birhanu ; Bekele, Abebe ; Deti, Tesfaye ; Wako, Getachew ; Shiferaw, Amsalu ; Tefera, Yohannes Lakew ; Kokebie, Melkamu Ayalew ; Anbessie, Tatek Bogale ; Wubie, Habtamu Teklie ; Wallace, Aaron ; Sugerman, Ciara E</creatorcontrib><description>Recommended vaccination at nine months of age with the measles-containing vaccine (MCV1) has been part of Ethiopia's routine immunization program since 1980. A second dose of MCV (MCV2) was introduced in 2019 for children 15 months of age. We examined MCV1 and MCV2 coverage and the factors associated with measles vaccination status. A cross-sectional household survey was conducted among caregivers of children aged 12-35 months in selected districts of Oromia Region. Measles vaccination status was determined using home-based records, when available, or caregivers' recall. We analyzed the association between MCV1 and MCV2 vaccination status and household, caregiver, and child factors using logistic regression. The caregivers of 1172 children aged 12-35 months were interviewed and included in the analysis. MCV1 and MCV2 coverage was 71% and 48%, respectively. The dropout rate (DOR) from the first dose of Pentavalent vaccine to MCV1 was 22% and from MCV1 to MCV2 was 46%. Caregivers were more likely to vaccinate their children with MCV if they gave birth at a health facility, believe that their child had received all recommended vaccines, and know the required number of vaccination visits and doses. MCV2 coverage was low, with a high measles dropout rate (DOR). Caregivers with high awareness of MCV and its schedule were more likely to vaccinate their children. Intensified demand generation, defaulter tracking, and vaccine-stock management should be strengthened to improve MCV uptake.</description><identifier>ISSN: 2076-393X</identifier><identifier>EISSN: 2076-393X</identifier><identifier>DOI: 10.3390/vaccines12070762</identifier><identifier>PMID: 39066400</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Age groups ; Caregivers ; Child health services ; Children ; Children & youth ; Data collection ; Demographic aspects ; Demographics ; Dosage and administration ; Epidemics ; Evaluation ; Health care facilities ; Health facilities ; Households ; Immunization ; immunization coverage ; Interviews ; Management ; MCV1 ; MCV2 ; Measles ; Measles vaccine ; measles-containing vaccine ; Questionnaires ; Regression analysis ; second year of life ; Vaccines</subject><ispartof>Vaccines (Basel), 2024-07, Vol.12 (7), p.762</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><rights>2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c385t-677d272e2eeaa7ec5650483e7b001197d1ea3588e5190de94dc5495aa4fcab433</cites><orcidid>0000-0003-0326-5971 ; 0000-0003-2264-3229 ; 0000-0002-1469-837X ; 0000-0003-3585-1625 ; 0009-0004-3135-8635 ; 0000-0001-8006-2401</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3085056225?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3085056225?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,27924,27925,37012,37013,38516,43895,44590,74412,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39066400$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Woyessa, Abyot Bekele</creatorcontrib><creatorcontrib>Shah, Monica P</creatorcontrib><creatorcontrib>Azmeraye, Binyam Moges</creatorcontrib><creatorcontrib>Pan, Jeff</creatorcontrib><creatorcontrib>Lisanwork, Leuel</creatorcontrib><creatorcontrib>Yimer, Getnet</creatorcontrib><creatorcontrib>Wang, Shu-Hua</creatorcontrib><creatorcontrib>Nuorti, J Pekka</creatorcontrib><creatorcontrib>Artama, Miia</creatorcontrib><creatorcontrib>Matanock, Almea M</creatorcontrib><creatorcontrib>An, Qian</creatorcontrib><creatorcontrib>Samuel, Paulos</creatorcontrib><creatorcontrib>Tolera, Bekana</creatorcontrib><creatorcontrib>Kenate, Birhanu</creatorcontrib><creatorcontrib>Bekele, Abebe</creatorcontrib><creatorcontrib>Deti, Tesfaye</creatorcontrib><creatorcontrib>Wako, Getachew</creatorcontrib><creatorcontrib>Shiferaw, Amsalu</creatorcontrib><creatorcontrib>Tefera, Yohannes Lakew</creatorcontrib><creatorcontrib>Kokebie, Melkamu Ayalew</creatorcontrib><creatorcontrib>Anbessie, Tatek Bogale</creatorcontrib><creatorcontrib>Wubie, Habtamu Teklie</creatorcontrib><creatorcontrib>Wallace, Aaron</creatorcontrib><creatorcontrib>Sugerman, Ciara E</creatorcontrib><title>Factors Associated with Uptake of Routine Measles-Containing Vaccine Doses among Young Children, Oromia Regional State, Ethiopia, 2021</title><title>Vaccines (Basel)</title><addtitle>Vaccines (Basel)</addtitle><description>Recommended vaccination at nine months of age with the measles-containing vaccine (MCV1) has been part of Ethiopia's routine immunization program since 1980. A second dose of MCV (MCV2) was introduced in 2019 for children 15 months of age. We examined MCV1 and MCV2 coverage and the factors associated with measles vaccination status. A cross-sectional household survey was conducted among caregivers of children aged 12-35 months in selected districts of Oromia Region. Measles vaccination status was determined using home-based records, when available, or caregivers' recall. We analyzed the association between MCV1 and MCV2 vaccination status and household, caregiver, and child factors using logistic regression. The caregivers of 1172 children aged 12-35 months were interviewed and included in the analysis. MCV1 and MCV2 coverage was 71% and 48%, respectively. The dropout rate (DOR) from the first dose of Pentavalent vaccine to MCV1 was 22% and from MCV1 to MCV2 was 46%. Caregivers were more likely to vaccinate their children with MCV if they gave birth at a health facility, believe that their child had received all recommended vaccines, and know the required number of vaccination visits and doses. MCV2 coverage was low, with a high measles dropout rate (DOR). Caregivers with high awareness of MCV and its schedule were more likely to vaccinate their children. Intensified demand generation, defaulter tracking, and vaccine-stock management should be strengthened to improve MCV uptake.</description><subject>Age groups</subject><subject>Caregivers</subject><subject>Child health services</subject><subject>Children</subject><subject>Children & youth</subject><subject>Data collection</subject><subject>Demographic aspects</subject><subject>Demographics</subject><subject>Dosage and administration</subject><subject>Epidemics</subject><subject>Evaluation</subject><subject>Health care facilities</subject><subject>Health facilities</subject><subject>Households</subject><subject>Immunization</subject><subject>immunization coverage</subject><subject>Interviews</subject><subject>Management</subject><subject>MCV1</subject><subject>MCV2</subject><subject>Measles</subject><subject>Measles vaccine</subject><subject>measles-containing vaccine</subject><subject>Questionnaires</subject><subject>Regression analysis</subject><subject>second year of life</subject><subject>Vaccines</subject><issn>2076-393X</issn><issn>2076-393X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUs1u1DAQjhCIVqV3TsgSFw67xY5jOzmulhYqFVUqFMHJmtiTXS9JvNgOiBfguXFJKVBhS57R6PsZ21MUTxk94byhL7-CMW7EyEqqqJLlg-IwZ3LJG_7x4V_5QXEc447m1TBeS_W4OMh0KStKD4sfZ2CSD5GsYvTGQUJLvrm0Jdf7BJ-R-I5c-SllH_IWIfYYl2s_JnCjGzfkw9wCeeUjRgKDz7VPfsrneut6G3BckMvgBwfkCjfOj9CTdymbLMhp2jq_d7AgJS3Zk-JRB33E49t4VFyfnb5fv1leXL4-X68ulobXIi2lUrZUJZaIAAqNkIJWNUfVUspYoyxD4KKuUbCGWmwqa0TVCICqM9BWnB8V57Ou9bDT--AGCN-1B6d_FXzYaAjJmR5104qWWwnYNlAxriA7SlZhlledsV3WejFr7YP_MmFMenDRYN_DiH6KmtNa5L-p6zJDn9-D7vwU8mvMKCpkWYo_qA1kfzd2PgUwN6J6VVOulJRUZdTJf1B5Wxyc8SN2Ltf_IdCZYIKPMWB3d29G9c0k6fuTlCnPbvud2gHtHeH33PCfBBvDeQ</recordid><startdate>20240701</startdate><enddate>20240701</enddate><creator>Woyessa, Abyot Bekele</creator><creator>Shah, Monica P</creator><creator>Azmeraye, Binyam Moges</creator><creator>Pan, Jeff</creator><creator>Lisanwork, Leuel</creator><creator>Yimer, Getnet</creator><creator>Wang, Shu-Hua</creator><creator>Nuorti, J Pekka</creator><creator>Artama, Miia</creator><creator>Matanock, Almea M</creator><creator>An, Qian</creator><creator>Samuel, Paulos</creator><creator>Tolera, Bekana</creator><creator>Kenate, Birhanu</creator><creator>Bekele, Abebe</creator><creator>Deti, Tesfaye</creator><creator>Wako, Getachew</creator><creator>Shiferaw, Amsalu</creator><creator>Tefera, Yohannes Lakew</creator><creator>Kokebie, Melkamu Ayalew</creator><creator>Anbessie, Tatek Bogale</creator><creator>Wubie, Habtamu Teklie</creator><creator>Wallace, Aaron</creator><creator>Sugerman, Ciara E</creator><general>MDPI AG</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T7</scope><scope>7XB</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0326-5971</orcidid><orcidid>https://orcid.org/0000-0003-2264-3229</orcidid><orcidid>https://orcid.org/0000-0002-1469-837X</orcidid><orcidid>https://orcid.org/0000-0003-3585-1625</orcidid><orcidid>https://orcid.org/0009-0004-3135-8635</orcidid><orcidid>https://orcid.org/0000-0001-8006-2401</orcidid></search><sort><creationdate>20240701</creationdate><title>Factors Associated with Uptake of Routine Measles-Containing Vaccine Doses among Young Children, Oromia Regional State, Ethiopia, 2021</title><author>Woyessa, Abyot Bekele ; Shah, Monica P ; Azmeraye, Binyam Moges ; Pan, Jeff ; Lisanwork, Leuel ; Yimer, Getnet ; Wang, Shu-Hua ; Nuorti, J Pekka ; Artama, Miia ; Matanock, Almea M ; An, Qian ; Samuel, Paulos ; Tolera, Bekana ; Kenate, Birhanu ; Bekele, Abebe ; Deti, Tesfaye ; Wako, Getachew ; Shiferaw, Amsalu ; Tefera, Yohannes Lakew ; Kokebie, Melkamu Ayalew ; Anbessie, Tatek Bogale ; Wubie, Habtamu Teklie ; Wallace, Aaron ; Sugerman, Ciara E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-677d272e2eeaa7ec5650483e7b001197d1ea3588e5190de94dc5495aa4fcab433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Age groups</topic><topic>Caregivers</topic><topic>Child health services</topic><topic>Children</topic><topic>Children & youth</topic><topic>Data collection</topic><topic>Demographic aspects</topic><topic>Demographics</topic><topic>Dosage and administration</topic><topic>Epidemics</topic><topic>Evaluation</topic><topic>Health care facilities</topic><topic>Health facilities</topic><topic>Households</topic><topic>Immunization</topic><topic>immunization coverage</topic><topic>Interviews</topic><topic>Management</topic><topic>MCV1</topic><topic>MCV2</topic><topic>Measles</topic><topic>Measles vaccine</topic><topic>measles-containing vaccine</topic><topic>Questionnaires</topic><topic>Regression analysis</topic><topic>second year of life</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Woyessa, Abyot Bekele</creatorcontrib><creatorcontrib>Shah, Monica P</creatorcontrib><creatorcontrib>Azmeraye, Binyam Moges</creatorcontrib><creatorcontrib>Pan, Jeff</creatorcontrib><creatorcontrib>Lisanwork, Leuel</creatorcontrib><creatorcontrib>Yimer, Getnet</creatorcontrib><creatorcontrib>Wang, Shu-Hua</creatorcontrib><creatorcontrib>Nuorti, J Pekka</creatorcontrib><creatorcontrib>Artama, Miia</creatorcontrib><creatorcontrib>Matanock, Almea M</creatorcontrib><creatorcontrib>An, Qian</creatorcontrib><creatorcontrib>Samuel, Paulos</creatorcontrib><creatorcontrib>Tolera, Bekana</creatorcontrib><creatorcontrib>Kenate, Birhanu</creatorcontrib><creatorcontrib>Bekele, Abebe</creatorcontrib><creatorcontrib>Deti, Tesfaye</creatorcontrib><creatorcontrib>Wako, Getachew</creatorcontrib><creatorcontrib>Shiferaw, Amsalu</creatorcontrib><creatorcontrib>Tefera, Yohannes Lakew</creatorcontrib><creatorcontrib>Kokebie, Melkamu Ayalew</creatorcontrib><creatorcontrib>Anbessie, Tatek Bogale</creatorcontrib><creatorcontrib>Wubie, Habtamu Teklie</creatorcontrib><creatorcontrib>Wallace, Aaron</creatorcontrib><creatorcontrib>Sugerman, Ciara E</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Vaccines (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Woyessa, Abyot Bekele</au><au>Shah, Monica P</au><au>Azmeraye, Binyam Moges</au><au>Pan, Jeff</au><au>Lisanwork, Leuel</au><au>Yimer, Getnet</au><au>Wang, Shu-Hua</au><au>Nuorti, J Pekka</au><au>Artama, Miia</au><au>Matanock, Almea M</au><au>An, Qian</au><au>Samuel, Paulos</au><au>Tolera, Bekana</au><au>Kenate, Birhanu</au><au>Bekele, Abebe</au><au>Deti, Tesfaye</au><au>Wako, Getachew</au><au>Shiferaw, Amsalu</au><au>Tefera, Yohannes Lakew</au><au>Kokebie, Melkamu Ayalew</au><au>Anbessie, Tatek Bogale</au><au>Wubie, Habtamu Teklie</au><au>Wallace, Aaron</au><au>Sugerman, Ciara E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors Associated with Uptake of Routine Measles-Containing Vaccine Doses among Young Children, Oromia Regional State, Ethiopia, 2021</atitle><jtitle>Vaccines (Basel)</jtitle><addtitle>Vaccines (Basel)</addtitle><date>2024-07-01</date><risdate>2024</risdate><volume>12</volume><issue>7</issue><spage>762</spage><pages>762-</pages><issn>2076-393X</issn><eissn>2076-393X</eissn><abstract>Recommended vaccination at nine months of age with the measles-containing vaccine (MCV1) has been part of Ethiopia's routine immunization program since 1980. A second dose of MCV (MCV2) was introduced in 2019 for children 15 months of age. We examined MCV1 and MCV2 coverage and the factors associated with measles vaccination status. A cross-sectional household survey was conducted among caregivers of children aged 12-35 months in selected districts of Oromia Region. Measles vaccination status was determined using home-based records, when available, or caregivers' recall. We analyzed the association between MCV1 and MCV2 vaccination status and household, caregiver, and child factors using logistic regression. The caregivers of 1172 children aged 12-35 months were interviewed and included in the analysis. MCV1 and MCV2 coverage was 71% and 48%, respectively. The dropout rate (DOR) from the first dose of Pentavalent vaccine to MCV1 was 22% and from MCV1 to MCV2 was 46%. Caregivers were more likely to vaccinate their children with MCV if they gave birth at a health facility, believe that their child had received all recommended vaccines, and know the required number of vaccination visits and doses. MCV2 coverage was low, with a high measles dropout rate (DOR). Caregivers with high awareness of MCV and its schedule were more likely to vaccinate their children. Intensified demand generation, defaulter tracking, and vaccine-stock management should be strengthened to improve MCV uptake.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>39066400</pmid><doi>10.3390/vaccines12070762</doi><orcidid>https://orcid.org/0000-0003-0326-5971</orcidid><orcidid>https://orcid.org/0000-0003-2264-3229</orcidid><orcidid>https://orcid.org/0000-0002-1469-837X</orcidid><orcidid>https://orcid.org/0000-0003-3585-1625</orcidid><orcidid>https://orcid.org/0009-0004-3135-8635</orcidid><orcidid>https://orcid.org/0000-0001-8006-2401</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2076-393X |
ispartof | Vaccines (Basel), 2024-07, Vol.12 (7), p.762 |
issn | 2076-393X 2076-393X |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_9b5b3d6aeb9a4137aaa7614e5887fcdf |
source | Access via ProQuest (Open Access); PubMed Central; Coronavirus Research Database |
subjects | Age groups Caregivers Child health services Children Children & youth Data collection Demographic aspects Demographics Dosage and administration Epidemics Evaluation Health care facilities Health facilities Households Immunization immunization coverage Interviews Management MCV1 MCV2 Measles Measles vaccine measles-containing vaccine Questionnaires Regression analysis second year of life Vaccines |
title | Factors Associated with Uptake of Routine Measles-Containing Vaccine Doses among Young Children, Oromia Regional State, Ethiopia, 2021 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T22%3A15%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20Associated%20with%20Uptake%20of%20Routine%20Measles-Containing%20Vaccine%20Doses%20among%20Young%20Children,%20Oromia%20Regional%20State,%20Ethiopia,%202021&rft.jtitle=Vaccines%20(Basel)&rft.au=Woyessa,%20Abyot%20Bekele&rft.date=2024-07-01&rft.volume=12&rft.issue=7&rft.spage=762&rft.pages=762-&rft.issn=2076-393X&rft.eissn=2076-393X&rft_id=info:doi/10.3390/vaccines12070762&rft_dat=%3Cgale_doaj_%3EA803776607%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c385t-677d272e2eeaa7ec5650483e7b001197d1ea3588e5190de94dc5495aa4fcab433%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3085056225&rft_id=info:pmid/39066400&rft_galeid=A803776607&rfr_iscdi=true |